Back
Oruka Therapeutics Vs. Neurogene Industry Stock Comparison
Sell
1
ORKA
Oruka Therapeutics
Last Price:
27.05
Seasonality Move:
--
Buy
75
NGNE
Neurogene
Last Price:
66.00
Seasonality Move:
58.98%
Sell
1
Oruka Therapeutics (ORKA)
is a Sell
Is Oruka Therapeutics a Buy, Sell or Hold?
- The current Oruka Therapeutics [ORKA] share price is $26.95. The Score for ORKA is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- ORKA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ORKA Stock Price Chart
What is Oruka Therapeutics's stock price today?
-
The Oruka Therapeutics share price today is $26.95
The current trend is relatively stagnant and ORKA is experiencing slight selling pressure.
NGNE Stock Price Chart
ORKA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 46.26 | Sell |
Chaikin Money Flow: | -49871 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.1 - 29.68) | Sell |
Bollinger Bands (100): | ( - ) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 75.97 | Buy |
Chaikin Money Flow: | 176225 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.28 - 53.36) | Buy |
Bollinger Bands (100): | (34.64 - 46.72) | Buy |
ORKA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.62 | Sell |
20-day SMA: | 28.54 | Sell |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 28.25 | Sell |
20-day EMA: | 28.16 | Sell |
50-day EMA: | 2.08 | Buy |
200-day EMA: | 0.54 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.43 | Buy |
20-day SMA: | 49.56 | Buy |
50-day SMA: | 43.32 | Buy |
200-day SMA: | 37.93 | Buy |
8-day EMA: | 50.65 | Buy |
20-day EMA: | 48.54 | Buy |
50-day EMA: | 44.96 | Buy |
200-day EMA: | 36.96 | Buy |
Oruka Therapeutics Earnings Growth & ORKA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.02 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Oruka Therapeutics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |